MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0238614
Equilife Laboratories Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹40.96 Lakh
▲ 39% YoY
Net loss · FY 2024
₹14.05 Lakh
Net margin -34.3%
EBITDA · FY 2024
-₹12.42 Lakh
EBITDA margin -30.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Equilife Laboratories Private Limited
Data last updated:
Equilife Laboratories Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 14 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24230PN2019PTC186087. Its GSTIN is 27AAFCE6004L1ZM (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dnyaneshwar Tukaram Singare and Ukha Dnyaneshwar Singare.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat A 104 Sn – 41/2 Sus Nea Bhtuv Com Baner Annexure, Pune, Maharashtra, India – 411021.
As per the financials filed for FY 2024, the company reported a revenue of ₹40.96 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net loss of ₹14.05 Lakh (net margin -34.3%) and EBITDA of -₹12.42 Lakh (EBITDA margin -30.3%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years.
Court records list 3 cases involving the company, including 3 filed by the company; 2 cases are pending.
Equilife Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0238614). For more details, the company can be reached via its website equilifelaboratories.com.
Company details
CIN U24230PN2019PTC186087
Registration Number 186087
Incorporation Date 14 August 2019
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0238614
Key People
Dnyaneshwar Tukaram Singare Director Ukha Dnyaneshwar Singare Director Shubhangi Anil Pagar Director Recognitions & Rankings of Equilife Laboratories
Contact details
Equilife Laboratories Private Limited's registered office is in Pune, Maharashtra. Its website is equilifelaboratories.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat A 104 Sn – 41/2 Sus Nea Bhtuv Com Baner Annexure, Pune, Maharashtra, India – 411021
- IndustryPharma, API Manufacturers
To see the full contact details of Equilife Laboratories Private Limited, buy the company report.
Comprehensive company report
Equilife Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Equilife Laboratories is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Equilife Laboratories Private Limited, buy the company report.
Financials of Equilife Laboratories Private Limited
FY 2025 filings availableEquilife Laboratories Private Limited reported revenue of ₹40.96 Lakh (up 39% YoY) for FY 2024.
Revenue · FY 2024
₹40.96 Lakh ▲ 39%
Net loss · FY 2024
₹14.05 Lakh margin -34.3%
EBITDA · FY 2024
-₹12.42 Lakh margin -30.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 454%
3 years · compounded
▼ 59%
Revenue rose 39% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 454% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -30.3% | ||||
| Net Profit Margin | -34.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Equilife Laboratories Private Limited, buy the company report.
Board of directors of Equilife Laboratories Private Limited
Equilife Laboratories has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dnyaneshwar Tukaram Singare | Director | 14 Aug 2019 | 7 Years 2 Months | Current |
| Ukha Dnyaneshwar Singare | Director | 14 Aug 2019 | 7 Years 2 Months | Current |
| Shubhangi Anil Pagar Also directs: KNK Agro Producer Company Limited | Director | 23 Apr 2021 | 5 Years 6 Months | Current |
Auditor
Equilife Laboratories Private Limited is audited by S K P N and Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S K P N and Associates LLP | FY 2023 | 154291W/W100923 |
Shareholding
The shareholding of Equilife Laboratories Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Equilife Laboratories Private Limited, buy the company report.
Legal cases
Equilife Laboratories Private Limited has 3 court cases on record: 3 filed by Equilife Laboratories. 2 cases are pending and 1 is disposed.
Total cases
3
Filed by the company
3
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Criminal miscellaneous application | Filed by the company against State of Maharashtra Through Hinjewadi Police Statio | Pending |
| District court, Pune, Maharashtra | Criminal miscellaneous application | Filed by the company against State of Maharashtra Through Bhosari Midc Police Station | Pending |
| District court, Pune, Maharashtra | Criminal miscellaneous application | Filed by the company against State of Maharashtra Through Hinjewadi Police Statio | Disposed |
To see the full case history of Equilife Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Equilife Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Equilife Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCE6004L1ZM | Maharashtra | Active | 04 Sep 2019 |
To see the full GST registrations and return filing status of Equilife Laboratories Private Limited, buy the company report.
Recent activity
Equilife Laboratories Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Shubhangi Anil Pagar ceased to be Additional Director on 30 Nov 2021.
AGM
Equilife Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Equilife Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Shubhangi Anil Pagar ceased to be Additional Director.
Appointed
Shubhangi Anil Pagar was appointed as Director.
Appointed
Dnyaneshwar Tukaram Singare was appointed as Director.
Appointed
Ukha Dnyaneshwar Singare was appointed as Director.
Incorporation
14 Aug 2019
Equilife Laboratories Private Limited was registered on 14 Aug 2019 with Roc Pune & aged 7 years 2 months as per MCA records.
Frequently asked questions
Equilife Laboratories is an active private limited company based in Pune, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 14 August 2019 (7+ years old) and is registered under CIN U24230PN2019PTC186087.
Equilife Laboratories has 3 current directors:
- Dnyaneshwar Tukaram Singare - Director
- Ukha Dnyaneshwar Singare - Director
- Shubhangi Anil Pagar - Director
The latest financial statements of Equilife Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Equilife Laboratories is 27AAFCE6004L1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Equilife Laboratories is U24230PN2019PTC186087. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Equilife Laboratories has 3 court cases on record: 3 filed by the company. 2 are pending.
Equilife Laboratories was incorporated on 14 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Shubhangi Anil Pagar ceased to be Additional Director on 30 Nov 2021. Shubhangi Anil Pagar was appointed as Director on 23 Apr 2021. Dnyaneshwar Tukaram Singare was appointed as Director on 14 Aug 2019. Equilife Laboratories has 4 board changes on record in total.
Yes, Equilife Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0238614).
Equilife Laboratories can be reached through the website equilifelaboratories.com. Its registered office is in Pune, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages